Cevimeline Hydrochloride Capsule
Product Images NDC 0713-0937

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cevimeline Hydrochloride (NDC 0713-0937). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cosette Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula For Cevimeline Is Cis -2’-methylspiro{1-azabicyclo [2.2.2] Octane-3, 5’-[1,3] Oxathiolane} Hydrochloride, Hydrate (2:1). Its Empirical Formula Is C10h17nos.hcl. (Cevimeline 01)

FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Label)

Principal Display Panel (30 mg Capsule Bottle Label)
This is a Cevebeline Hydrochloride capsule medication manufactured by Cossette Pharmaceuticals Inc. Each capsule contains 30 mg of the drug, and the package insert should be consulted for dosage and administration advice. The medication should be stored tightly, and kept out of reach of children. Excursions up to 15°-30°C (59°-86°F) are allowed, but the recommended storage temperature is 25°C (77°F). The text also includes identifiers and the date of issuance.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.